NOVORON BIOSCIENCE INC
Last verified 2026-05-08. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $1.3Mattributed |
|---|---|
| Latest round | grant, $1.3M, 2025-01-01attributed |
| Founded | unknown |
| Headquarters | san diego, ca, usa |
| Industry | unknown |
| Stage | unknown |
| Website | novoron.com |
Novoron Bioscience develops lipoprotein-receptor therapies for neurological health and repair across proteinopathies and spinal-cord injury. It targets patients seeking restoration of independence after neurodegenerative or traumatic damage. The company emphasises avoiding false-negative shutdowns over fail-fast triage in its preclinical portfolio.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-01-01 | grant | $1.3M | undisclosed |
Detected tech stack
Typekit, Adobe Fonts, Afterpay, Sentry, Squarespace, Squarespace Commerce, Stimulus, parallax.js, web-vitals, moment 0, @sentry/browser
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $1.3M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $1.3M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | novoron.com, read 2026-05-08 |
| Description | self-reported | novoron.com, read 2026-05-08 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.